ient amount of 100 mM ammonium bicarbonate buffer containing 2 mM CaCl2 and CEP32496 chemical information incubated overnight at 37uC. Samples were sonicated for 5 min and supernatant was pooled with an additional peptide extraction round with 50% acetonitrile/1% formic acid for 20 min at RT. Samples were dried under vacuum and kept at 220uC whenever they were not used immediately. Histoblot analysis Cryosections were transferred to a nitrocellulose membrane and digested for 4 h with 20 mg/ml of proteinase K at 24900801 37uC. Blocking of the sections was done in 5% TopBlock, incubation with primary and secondary antibodies were done in 1% TopBlock, respectively. The blots were incubated in BCIP/NBT in B3 buffer for 4560 min. ICAT labeling and sample processing The IP eluate was precipitated by ethanol precipitation and the pellet was dissolved in 100 ml of cICAT labeling buffer. The cICAT labeling procedures was performed as described previously. The control sample was labeled with the light, the specific elution sample with heavy cICAT label. Digestion with trypsin was performed at 37uC over night and ICAT-labeled peptides were subsequently purified according to the manufacturer’s instructions. ZipTip columns Scrapie cell assay in endpoint format Prion-susceptible neuroblastoma cells were exposed to 300 ml brain homogenates in 96-well plates for 3 d. Cells were subsequently split three times 1:3 every 2 days, and three times 1:10 every 3 days. After they reached confluence, we Interactome of Myc-Tagged PrP were then used for further cleanup of the affinity-purified fraction. Capillary chromatography and mass spectrometric analysis Cleaned samples were resuspended in equilibration buffer and loaded onto a microcapillary column constructed by slurry packing 8 cm of reversed-phase material 
into a 75 mm fused-silica capillary. Mass spectrometric analyses were performed on an LTQ-FTTM systems directly coupled to a nanoLCTM HPLC system at a flow rate of 200 nl/min. Peptides were eluted with an acetonitrile gradient from 3 to 45% in approximately 55 min and datadependent acquisition of tandem mass spectra was continuously repeated during the course of the analysis. Each high accuracy MS full scan was followed by four MS/MS scans of the four most intense peaks. High mass accuracy data was search with Mascot Integra using the UniProt mouse protein data base, allowing for 10604956 two missed trypsin cleavage sites and precursor- and fragment ion tolerances of 5 ppm and 0.8 Da, respectively. Peptides from ICAT samples were identified by searching MS/MS spectra against the same mouse protein database using Sequest. PeptidePhrophet was used to assess the validity of peptide assignments. Proteins were filtered using ProteinProphet with a computed overall probability of $0.95 for a protein being present in the sample. Only peptide pairs that had a mass difference of 9.0301 Da were included. Both peptide contained cysteins and belonged to a protein that was identified with an Xcorr value$1.5. Averages and standard deviations were calculated for each protein expression value when multiple peptide measurements were available. We only considered peptides with double and multiple charges, and manually evaluated the expression values by inspecting the areas of integration that the software had chosen and by adjusting them as needed. To calculate protein ratio between different pull down samples, XPRESS was used. passage 5.0) brain homogenate, prepared as described. Beginning 50 days after inoculation, m
